Teligent Property, Plant, and Equipment 2010-2021 | TLGT

Teligent property, plant, and equipment from 2010 to 2021. Property, plant, and equipment can be defined as the sum of all net property, plant & Equipment fields. Where companies do not report a break down of plant, property, & equipment, the value is entered in this field alone.
Teligent Annual Property, Plant, and Equipment
(Millions of US $)
2020 $16
2019 $96
2018 $92
2017 $68
2016 $26
2015 $9
2014 $3
2013 $3
2012 $3
2011 $3
2010 $3
2009 $3
Teligent Quarterly Property, Plant, and Equipment
(Millions of US $)
2021-06-30 $16
2021-03-31 $16
2020-12-31 $16
2020-09-30 $96
2020-06-30 $97
2020-03-31 $96
2019-12-31 $96
2019-09-30 $96
2019-06-30 $96
2019-03-31 $94
2018-12-31 $92
2018-09-30 $88
2018-06-30 $83
2018-03-31 $77
2017-12-31 $68
2017-09-30 $57
2017-06-30 $45
2017-03-31 $34
2016-12-31 $26
2016-09-30 $20
2016-06-30 $16
2016-03-31 $11
2015-12-31 $9
2015-09-30 $7
2015-06-30 $4
2015-03-31 $3
2014-12-31 $3
2014-09-30 $3
2014-06-30 $3
2014-03-31 $3
2013-12-31 $3
2013-09-30 $3
2013-06-30 $3
2013-03-31 $3
2012-12-31 $3
2012-09-30 $3
2012-06-30 $3
2012-03-31 $3
2011-12-31 $3
2011-09-30 $3
2011-06-30 $3
2011-03-31 $3
2010-12-31 $3
2010-09-30 $3
2010-06-30 $3
2010-03-31 $3
2009-12-31 $3
2009-09-30 $3
2009-06-30 $3
2009-03-31 $2
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.000B $0.000B
Teligent, Inc. is a specialty generic pharmaceutical company, develops, manufactures and markets topical formulations primarily in the United States. It sells generic pharmaceutical products in topical, injectable, complex and ophthalmic dosage forms. Teligent Inc., formerly known as IGI Laboratories, Inc., is based in Buena, New Jersey.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $19.350B 6.35
Dr Reddy's Laboratories (RDY) India $11.677B 22.35
BridgeBio Pharma (BBIO) United States $4.392B 0.00
Bausch Health Cos (BHC) Canada $3.009B 2.18
Amphastar Pharmaceuticals (AMPH) United States $2.142B 12.88
Supernus Pharmaceuticals (SUPN) United States $1.978B 26.93
Taysha Gene Therapies (TSHA) United States $0.447B 31.14
Personalis (PSNL) United States $0.239B 0.00
Assembly Biosciences (ASMB) United States $0.094B 0.00
Sol-Gel Technologies (SLGL) Israel $0.013B 0.00
Evoke Pharma (EVOK) United States $0.007B 0.00